Cambridge Epigenetix Funding: $146M Raised, Series D (2021)
Cambridge Epigenetix is based in Cambridge, Country. It has raised $146M in total funding. Latest round: Series D. Backed by Temasek, Third Point, GV.
Cambridge Epigenetix funding overview
Cambridge Epigenetix is based in Cambridge, Country. Cambridge Epigenetix has raised $146M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in November 2021. The round record for Cambridge Epigenetix runs through 2021; nothing later has been disclosed. Investors on record include Temasek, Third Point, GV, New Science Ventures, Ahren Innovation Capital, Sequoia. 6 distinct backers are named across the disclosed rounds.
Cambridge Epigenetix at a glance
Total raised
$146M
Latest round
Series D
Latest round date
November 2021
Headquarters
Cambridge, Country
Notable investors
Temasek, Third Point, GV, New Science Ventures, Ahren Innovation Capital, Sequoia
Frequently asked about Cambridge Epigenetix funding
How much has Cambridge Epigenetix raised?
Cambridge Epigenetix has raised $146M in total disclosed funding across the rounds on record.
Who has invested in Cambridge Epigenetix?
Temasek, Third Point, GV, New Science Ventures, Ahren Innovation Capital, Sequoia are named among the investors backing Cambridge Epigenetix.
What was the latest Cambridge Epigenetix funding round?
The most recent disclosed round is a Series D, announced in November 2021.
Where is Cambridge Epigenetix based?
Cambridge Epigenetix is based in Cambridge, Country.
When did Cambridge Epigenetix last raise?
The last disclosed Cambridge Epigenetix round closed in November 2021 at Series D.
We update the Cambridge Epigenetix record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
